Meningiomas and Treatment With CYPROTERONE ACETATE or Progestin: Retrospective Study in Patients Followed at the CHRU of Brest
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 110
- 试验地点
- 1
- 主要终点
- Diagnosis of meningiomas caracteristics
研究概览
简要总结
Investigators observe an increase risk of meningioma in patient treated by CYPROTERONE ACETATE or other form of progestin. Investigatorsdiscribe caractéristics of meningioma and treatement of the patients follow up in CHRU of Brest
详细描述
Retrospective study in CHRU of brest, the investigators selected patient with history of méningioma and treated by CYPROTERONE ACETATE, CHLORMADINONE ACETATE and NOMEGESTROL ACETATE essentially The investigators excluded patient with risk factor of meningioma added at hormonal treatment exposition The investigators discribe the caractéristique of patients: age, sex, duration of the treatment, the caractéristique of the meningioma: localization, grade, hormonal receptors, treatment by surgery or radiotherapy and changing after discontinuation of treatment
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •minimum 18 years
- •medical follow up in CHRU of Brest
- •treated by CYPROTERONE ACETATE and/or CHLORMADINONE ACETATE NOMEGESTROL ACETATE, PROGESTERONE , DYDROGESTERONE PROMEGESTONE , NORETHISTERONE, LEVONORGESTREL , oestroprogestogenic contraception
- •meningioma after treatement by progestin or CYPROTERONE ACETATE
排除标准
- •history ofbreast cancer
- •history of cerebral radiotherapy
- •history of neurofibromatosis
- •meningioma before treatement by progestin or CYPROTERONE ACETATE
- •minor patient
结局指标
主要结局
Diagnosis of meningiomas caracteristics
时间窗: 12 months
meningiomas caracteristics in patient treated with CYPROTERONE ACETATE or Progestin description
次要结局
- prescription status of progestogenic treatment(12 months)